LMR Partners’s AbbVie ABBV Stock Holding History

LMR Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,300	Closed	-$3.04M	–	1421
2025 Q4	$3.04M	Hold	13,300	–	–	0.01%	712
2025 Q3	$3.08M	Sell	13,300 -4,500	-25%	-$916K	0.01%	628
2025 Q2	$3.3M	Sell	17,800 -6,000	-25%	-$1.12M	0.02%	550
2025 Q1	$4.99M	Buy	+23,800	New	+$4.63M	0.05%	409
2024 Q2	–	Sell	-28,600	Closed	-$5.21M	–	1087
2024 Q1	$5.21M	Hold	28,600	–	–	0.05%	313
2023 Q4	$4.43M	Buy	+28,600	New	+$4.17M	0.05%	336

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LMR Partners's ABBV Position: Q2 2026 in Review

LMR Partners opened a new position in AbbVie (ABBV) in Q2 2026: 79,736 shares worth $20.1M. The stake represents 0.07% of the portfolio and ranks #237 among its holdings. This is a return to the name: LMR Partners previously reported a position in ABBV as recently as Q4 2025.

LMR Partners first reported a position in ABBV in Q3 2014 and has held it in 29 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LMR Partners held 79,736 shares of AbbVie worth $20.1M as of Q2 2026.
AbbVie was a new LMR Partners position in Q2 2026.
AbbVie made up 0.07% of LMR Partners's portfolio in Q2 2026, its #237 holding.
LMR Partners first reported a position in AbbVie in Q3 2014 and has held it in 29 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.